公开(公告)号：US20200289636A1

公开(公告)日：2020-09-17

申请号：US16645417

申请日：2018-09-06

Applicant: Hawaii Biotech, Inc.

Inventor： David E. CLEMENTS ,  Michael M. LIEBERMAN ,  Axel T. LEHRER

IPC: A61K39/12 ,  A61P31/14 ,  A61K39/295

Abstract: The data reported herein describe the production and evaluation of a recombinant subunit filovirus vaccine using insect cell expressed surface glycoprotein (GP) and a highly effective adjuvant. The vaccine provides protection in humans against filovirus infection, including Ebola virus and Marburg virus.

公开(公告)号：US20220080037A1

公开(公告)日：2022-03-17

申请号：US17537336

申请日：2021-11-29

Applicant: Hawaii Biotech, Inc.

Inventor： David E. CLEMENTS ,  Michael M. LIEBERMAN ,  Axel T. LEHRER

IPC: A61K39/12 ,  A61P31/14 ,  A61K39/295

Abstract: The data reported herein describe the production and evaluation of a recombinant subunit filovirus vaccine using insect cell expressed surface glycoprotein (GP) and a highly effective adjuvant. The vaccine provides protection in humans against filovirus infection, including Ebola virus and Marburg virus.